<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:trackback="http://madskills.com/public/xml/rss/module/trackback/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:pingback="http://madskills.com/public/xml/rss/module/pingback/" version="2.0">
  <channel>
    <title>IGG America</title>
    <link>http://www.iggamerica.com/blog/</link>
    <description />
    <language>en-us</language>
    <copyright>IGG America</copyright>
    <lastBuildDate>Mon, 26 Mar 2007 15:52:56 GMT</lastBuildDate>
    <generator>newtelligence dasBlog 1.8.5223.2</generator>
    <managingEditor>info@iggamerica.com</managingEditor>
    <webMaster>info@iggamerica.com</webMaster>
    <item xml:lang="en-US">
      <trackback:ping>http://www.iggamerica.com/blog/Trackback.aspx?guid=2362f789-2c64-4e99-8837-1b8a6f202510</trackback:ping>
      <pingback:server>http://www.iggamerica.com/blog/pingback.aspx</pingback:server>
      <pingback:target>http://www.iggamerica.com/blog/PermaLink,guid,2362f789-2c64-4e99-8837-1b8a6f202510.aspx</pingback:target>
      <dc:creator>myemail@myemail.com (Your DisplayName here!)</dc:creator>
      <title>Why is there an IVIg shortage?</title>
      <guid>http://www.iggamerica.com/blog/PermaLink,guid,2362f789-2c64-4e99-8837-1b8a6f202510.aspx</guid>
      <link>http://www.iggamerica.com/blog/PermaLink,guid,2362f789-2c64-4e99-8837-1b8a6f202510.aspx</link>
      <pubDate>Mon, 26 Mar 2007 15:52:56 GMT</pubDate>
      <description>&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align=center&gt;
   &lt;b style="mso-bidi-font-weight: normal"&gt;&lt;span style="FONT-SIZE: 18pt"&gt;&lt;font color=#000000&gt;&lt;font face="Times New Roman"&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;Why
   is there an IVIg shortage?&lt;o:p&gt;&lt;/o:p&gt;
   &lt;/font&gt;&lt;/font&gt;&lt;/span&gt;&lt;/b&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align=center&gt;
   &lt;b style="mso-bidi-font-weight: normal"&gt;&lt;span style="FONT-SIZE: 18pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
   &lt;/span&gt;&lt;/b&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;font face="Times New Roman" color=#000000 size=3&gt;Immune globulin (&lt;i style="mso-bidi-font-style: normal"&gt;also
   known as IVIg, IGIV, or IgG&lt;/i&gt;) is a plasma derived product prescribed to treat various
   immune deficient and autoimmune diseases.&lt;span style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/span&gt;Over
   the past several years, many patients, physician practices, and hospitals have experienced
   difficulties acquiring IVIg.&lt;span style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/span&gt;Several
   factors have contributed to this shortage situation:&lt;/font&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -0.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in"&gt;
   &lt;font face="Times New Roman"&gt;&lt;span style="FONT-SIZE: 14pt"&gt;&lt;span style="mso-list: Ignore"&gt;&lt;font color=#000000&gt;-&lt;span style="FONT: 7pt 'Times New Roman'"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/font&gt;&lt;/span&gt;&lt;/span&gt;&lt;b style="mso-bidi-font-weight: normal"&gt;&lt;span style="FONT-SIZE: 14pt"&gt;&lt;font color=#000000&gt;Industry
   consolidation.&lt;span style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/span&gt;
   &lt;o:p&gt;&lt;/o:p&gt;
   &lt;/font&gt;&lt;/span&gt;&lt;/b&gt;&lt;/font&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt 0.5in"&gt;
   &lt;font face="Times New Roman" color=#000000 size=3&gt;&lt;?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" /&gt;In
   2002, there were five IVIg manufacturers based in the 
   &lt;st1:place w:st="on"&gt;
      &lt;st1:country-region w:st="on"&gt;United States&lt;/st1:country-region&gt;
   &lt;/st1:place&gt;
   .&lt;span style="mso-spacerun: yes"&gt;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/font&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt 0.5in"&gt;
   &lt;font face="Times New Roman" color=#000000 size=3&gt;&lt;span style="mso-spacerun: yes"&gt;&lt;/span&gt;Today,
   there are three.&lt;/font&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt 0.25in"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -0.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in"&gt;
   &lt;font face="Times New Roman"&gt;&lt;span style="FONT-SIZE: 14pt"&gt;&lt;span style="mso-list: Ignore"&gt;&lt;font color=#000000&gt;-&lt;span style="FONT: 7pt 'Times New Roman'"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/font&gt;&lt;/span&gt;&lt;/span&gt;&lt;b style="mso-bidi-font-weight: normal"&gt;&lt;span style="FONT-SIZE: 14pt"&gt;&lt;font color=#000000&gt;Worldwide
   shortage of raw (donated) blood plasma.&lt;span style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/span&gt;
   &lt;o:p&gt;&lt;/o:p&gt;
   &lt;/font&gt;&lt;/span&gt;&lt;/b&gt;&lt;/font&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt 0.5in"&gt;
   &lt;font face="Times New Roman" color=#000000 size=3&gt;IVIg is extracted from plasma through
   a manufacturing process&lt;/font&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;font size=3&gt;&lt;font color=#000000&gt;&lt;font face="Times New Roman"&gt;&lt;span style="mso-spacerun: yes"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;called
   “fractionation”. &lt;/font&gt;&lt;/font&gt;&lt;/font&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -0.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in"&gt;
   &lt;font face="Times New Roman"&gt;&lt;span style="FONT-SIZE: 14pt"&gt;&lt;span style="mso-list: Ignore"&gt;&lt;font color=#000000&gt;-&lt;span style="FONT: 7pt 'Times New Roman'"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/font&gt;&lt;/span&gt;&lt;/span&gt;&lt;b style="mso-bidi-font-weight: normal"&gt;&lt;span style="FONT-SIZE: 14pt"&gt;&lt;font color=#000000&gt;Health
   insurance payments to providers (home health companies, physicians, hospitals) have
   significantly decreased in recent years.&lt;span style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/span&gt;
   &lt;o:p&gt;&lt;/o:p&gt;
   &lt;/font&gt;&lt;/span&gt;&lt;/b&gt;&lt;/font&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt 0.5in"&gt;
   &lt;font face="Times New Roman" color=#000000 size=3&gt;Reimbursement reductions, particularly
   by Medicare, have created &lt;/font&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt 0.5in"&gt;
   &lt;font face="Times New Roman" color=#000000 size=3&gt;scenarios whereby providers cannot
   cover their costs for administering IVIg treatments to patients.&lt;/font&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -0.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in"&gt;
   &lt;font face="Times New Roman"&gt;&lt;span style="FONT-SIZE: 14pt"&gt;&lt;span style="mso-list: Ignore"&gt;&lt;font color=#000000&gt;-&lt;span style="FONT: 7pt 'Times New Roman'"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/font&gt;&lt;/span&gt;&lt;/span&gt;&lt;b style="mso-bidi-font-weight: normal"&gt;&lt;span style="FONT-SIZE: 14pt"&gt;&lt;font color=#000000&gt;Most
   IVIg products/brands have been on allocation since&lt;o:p&gt;&lt;/o:p&gt;
   &lt;/font&gt;&lt;/span&gt;&lt;/b&gt;&lt;/font&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt 0.5in"&gt;
   &lt;b style="mso-bidi-font-weight: normal"&gt;&lt;span style="FONT-SIZE: 14pt"&gt;&lt;font color=#000000&gt;&lt;font face="Times New Roman"&gt;2004.&lt;o:p&gt;&lt;/o:p&gt;
   &lt;/font&gt;&lt;/font&gt;&lt;/span&gt;&lt;/b&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt 0.5in"&gt;
   &lt;font face="Times New Roman" color=#000000 size=3&gt;This means that providers can only
   acquire a specific amount of IVIg each month.&lt;span style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/span&gt;Once
   the monthly allocation has been dispensed, it can be difficult to secure additional
   IVIg for patients.&lt;/font&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align=center&gt;
   &lt;b style="mso-bidi-font-weight: normal"&gt;&lt;span style="FONT-SIZE: 18pt"&gt;&lt;font color=#000000&gt;&lt;font face="Times New Roman"&gt;What
   can you do to ensure access to IVIg treatments in the future?&lt;o:p&gt;&lt;/o:p&gt;
   &lt;/font&gt;&lt;/font&gt;&lt;/span&gt;&lt;/b&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align=center&gt;
   &lt;b style="mso-bidi-font-weight: normal"&gt;&lt;span style="FONT-SIZE: 18pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
   &lt;/span&gt;&lt;/b&gt;
&lt;/p&gt;
&lt;ol style="MARGIN-TOP: 0in" type=1&gt;
   &lt;li class=MsoNormal style="MARGIN: 0in 0in 0pt; mso-list: l1 level1 lfo2; tab-stops: list .5in"&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;If you are currently receiving IVIg
      treatments, contact your provider and inquire about their IVIg capabilities.&lt;span style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/span&gt;Are
      they receiving an allocation for IVIg?&lt;span style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/span&gt;What
      brand(s) of IVIg can they provide?&lt;span style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/span&gt;Do
      they carry an inventory of IVIg products in case they run into allocation issues?&lt;/font&gt;
   &lt;/li&gt;
&lt;/ol&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
&lt;/p&gt;
&lt;ol style="MARGIN-TOP: 0in" type=1 start=2&gt;
   &lt;li class=MsoNormal style="MARGIN: 0in 0in 0pt; mso-list: l1 level1 lfo2; tab-stops: list .5in"&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;If you are contemplating IVIg treatments,
      identify providers that will commit to supplying your IVIg needs on an ongoing basis.
      Remember, providers are on allocation for IVIg and many will only be able to guarantee
      IVIg on a month-to-month basis.&lt;/font&gt;
   &lt;/li&gt;
&lt;/ol&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;span style="mso-spacerun: yes"&gt;&lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&amp;nbsp; &lt;/font&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
&lt;/p&gt;
&lt;ol style="MARGIN-TOP: 0in" type=1 start=3&gt;
   &lt;li class=MsoNormal style="MARGIN: 0in 0in 0pt; mso-list: l1 level1 lfo2; tab-stops: list .5in"&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;Understand your health insurance
      coverage policy on IVIg.&lt;span style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/span&gt;Insurance coverage
      can vary: &lt;span style="mso-spacerun: yes"&gt;&amp;nbsp;&lt;/span&gt;based on your diagnosis; &lt;span style="mso-spacerun: yes"&gt;&amp;nbsp;&lt;/span&gt;the
      dollar amount reimbursed by the insurance company; &lt;span style="mso-spacerun: yes"&gt;&amp;nbsp;&lt;/span&gt;and
      the approved location (home, physician’s office, or hospital outpatient center) for
      your IVIg treatments.&lt;/font&gt;
   &lt;/li&gt;
&lt;/ol&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;font face="Times New Roman" color=#000000 size=3&gt;If you have any additional IVIg-related
   questions, please call 1.877.674.9700&lt;/font&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;font face="Times New Roman" color=#000000 size=3&gt;or visit &lt;/font&gt;&lt;a href="http://www.iggamerica.com/"&gt;&lt;font face="Times New Roman" size=3&gt;www.iggamerica.com&lt;/font&gt;&lt;/a&gt;&lt;font face="Times New Roman" color=#000000 size=3&gt;.&lt;/font&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;span style="mso-spacerun: yes"&gt;&lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&amp;nbsp; &lt;/font&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;span style="mso-spacerun: yes"&gt;&lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/font&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt 0.5in"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align=center&gt;
   &lt;b style="mso-bidi-font-weight: normal"&gt;&lt;span style="FONT-SIZE: 18pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
   &lt;/span&gt;&lt;/b&gt;
&lt;/p&gt;
&lt;p class=MsoNormal style="MARGIN: 0in 0in 0pt"&gt;
   &lt;o:p&gt;
      &lt;font face="Times New Roman" color=#000000 size=3&gt;&amp;nbsp;&lt;/font&gt;
   &lt;/o:p&gt;
&lt;/p&gt;
&lt;p&gt;
   &amp;nbsp;
&lt;/p&gt;</description>
      <category>News</category>
    </item>
    <item>
      <trackback:ping>http://www.iggamerica.com/blog/Trackback.aspx?guid=c31a49d7-f346-47ed-8cc8-91437c07f2ac</trackback:ping>
      <pingback:server>http://www.iggamerica.com/blog/pingback.aspx</pingback:server>
      <pingback:target>http://www.iggamerica.com/blog/PermaLink,guid,c31a49d7-f346-47ed-8cc8-91437c07f2ac.aspx</pingback:target>
      <dc:creator>myemail@myemail.com (Your DisplayName here!)</dc:creator>
      <body xmlns="http://www.w3.org/1999/xhtml">
        <p>
          <font face="Arial" color="#0000ff">Updates to follow soon</font>
        </p>
      </body>
      <title>Welcome to the IgG America Update Section</title>
      <guid>http://www.iggamerica.com/blog/PermaLink,guid,c31a49d7-f346-47ed-8cc8-91437c07f2ac.aspx</guid>
      <link>http://www.iggamerica.com/blog/PermaLink,guid,c31a49d7-f346-47ed-8cc8-91437c07f2ac.aspx</link>
      <pubDate>Wed, 21 Feb 2007 17:00:28 GMT</pubDate>
      <description>&lt;p&gt;
   &lt;font face=Arial color=#0000ff&gt;Updates to follow soon&lt;/font&gt;
&lt;/p&gt;</description>
      <category>News</category>
    </item>
  </channel>
</rss>